Overview:
The chart presents a technical analysis of Aurobindo Pharma Ltd. on a daily timeframe. The stock shows a recovery pattern with a visible RSI divergence, indicating a potential bullish reversal.
Key Observations:
1.RSI Divergence:
2.Critical Support Levels:
3.Potential Resistance Zones:
4.Buying Strategy:
5.Volume Analysis:
Conclusion:
Aurobindo Pharma shows signs of a potential bullish reversal. Traders should closely observe the ₹1,273.35 support level and enter only upon confirmation. Targets are placed at ₹1,310.80, ₹1,346.60, and beyond. Implement proper risk management to account for potential volatility.
The chart presents a technical analysis of Aurobindo Pharma Ltd. on a daily timeframe. The stock shows a recovery pattern with a visible RSI divergence, indicating a potential bullish reversal.
Key Observations:
1.RSI Divergence:
- A bullish divergence is identified as the price made lower lows while the RSI formed higher lows, signaling waning bearish momentum and the likelihood of an upward move.
2.Critical Support Levels:
- Immediate support is marked at ₹1,273.35, corresponding to the 200-day moving average.
- A strong base exists at ₹1,199.40 and ₹1,101.55, which acted as previous demand zones.
3.Potential Resistance Zones:
- Initial resistance levels are observed at ₹1,310.80 and ₹1,346.60.
- Major resistance is seen at ₹1,403.25 and ₹1,450.35, where the stock could face selling pressure.
4.Buying Strategy:
- Enter long positions only if the price stabilizes above ₹1,273.35, confirming support.
- Watch for a breakout above ₹1,310.80 for momentum trades targeting higher resistance levels.
5.Volume Analysis:
- Increased volume on recent upward moves supports the bullish sentiment.
- Monitor volume patterns for confirmation of breakouts or trend reversals.
Conclusion:
Aurobindo Pharma shows signs of a potential bullish reversal. Traders should closely observe the ₹1,273.35 support level and enter only upon confirmation. Targets are placed at ₹1,310.80, ₹1,346.60, and beyond. Implement proper risk management to account for potential volatility.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。